AVANTAGE® RELOAD Double Mobility Acetabular Cup -Clinical Study
← catalyst calendarNCT03357445 · readout in 251 d
Sponsored by Zimmer Biomet (industry) · ZBH — their whole pipeline →.
Phase
Not applicable
Status
Active, not recruiting
Study type
Interventional
Design
Randomized · Single · Other
Enrollment
500actual
Sites
4
Countries
France, Slovenia
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2011-10-14 | actual | When the study began enrolling |
| Primary completion | 2027-04-27 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2027-04-27 | estimated | The whole study's end, after follow-up |
| First posted | 2017-11-29 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2024-11-14 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Primary Osteoarthritis
- Post-Traumatic Arthritis
- Inflammatory Joint Disease
- Femoral Neck Fracture
- Femoral Head Necrosis
- Sequelae From Previous Hip Surgery
- Osteotomies
- Congenital Hip Dysplasia
Intervention
- Other: Avantage Reload cup
Primary outcome
what the primary-completion date above is the date OFSurvivorship
measured 10 years post-surgery
Permalink · ZBH's whole pipeline · Catalyst calendar · Every registered study · What changed